Bifunctional Silk Nanospheres for Targeted Delivery of Oligonucleotide Therapeutics to VEGFR-Positive Cells in the Tumor Microenvironment
Biomacromolecules · 2026
DOI: 10.1021/acs.biomac.5c02041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2026. Verfasst von Patryk Lorenc und 4 weiteren Autor:innen. Beteiligte Einrichtung: Poznan University of Medical Sciences, Department of Cancer Immunology, 8 Rokietnicka St, 60-806 Poznan, Poland. Hauptthemen laut MEDLINE: Nanospheres, Tumor Microenvironment, RNA, Small Interfering, Vascular Endothelial Growth Factor Receptor-2. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Poznan University of Medical Sciences, Department of Cancer Immunology, 8 Rokietnicka St, 60-806 Poznan, Poland.
- Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 15 Garbary St, 61-866 Poznan, Poland.
- Doctoral School, Poznan University of Medical Sciences, 70 Bukowska St, 60-812 Poznan, Poland.
ORCID-Profile: Hanna Dams-Kozlowska, Anna Florczak-Substyk
Förderung
- Narodowe Centrum Nauki
Zitieren
APA
Lorenc, P., Deptuch, T., Sikorska, A., Dams-Kozlowska, H., & Florczak-Substyk, A. (2026). Bifunctional Silk Nanospheres for Targeted Delivery of Oligonucleotide Therapeutics to VEGFR-Positive Cells in the Tumor Microenvironment. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c02041
Vancouver
Lorenc P, Deptuch T, Sikorska A, Dams-Kozlowska H, Florczak-Substyk A. Bifunctional Silk Nanospheres for Targeted Delivery of Oligonucleotide Therapeutics to VEGFR-Positive Cells in the Tumor Microenvironment. Biomacromolecules. 2026. doi:10.1021/acs.biomac.5c02041
BibTeX
@article{Lorenc2026,
author = {Lorenc, Patryk and Deptuch, Tomasz and Sikorska, Agata and Dams-Kozlowska, Hanna and Florczak-Substyk, Anna},
title = {Bifunctional Silk Nanospheres for Targeted Delivery of Oligonucleotide Therapeutics to VEGFR-Positive Cells in the Tumor Microenvironment},
journal = {Biomacromolecules},
year = {2026},
doi = {10.1021/acs.biomac.5c02041}
}
EUVIMED